Table 3 Cost of blister-packaged artesunate and mefloquine
From: Cost of increasing access to artemisinin combination therapy: the Cambodian experience
Drug package | Actual cost (at 9.5% productivity) | Potential cost (at full productivity) | ||
|---|---|---|---|---|
Recurrent costs | Recurrent and capital costs | Recurrent costs | Recurrent and capital costs | |
A+M2 (Art 50 mg × 6 + Mef 250 mg × 2) | 2.307 | 2.595 | 1.386 | 1.420 |
A+M3* (Art 50 mg × 9 + Mef 250 mg × 3) | 2.894 | 3.182 | 1.973 | 2.007 |
A+M4 (Art 50 mg × 12 + Mef 250 mg × 4) | 3.480 | 3.769 | 2.560 | 2.594 |
Malarine® (adult) (Art 200 mg × 3 + Mef 250 mg × 4) | 3.608 | 3.896 | 2.688 | 2.722 |